PLXSPlexus Corp — stock analysis & sentiment

Plexus closed at $263.33, roughly 14% below its 52-week high of $307.06 and close to double its 52-week low of $132.03. That range is wide for a company of this size — the high sits more than twice the low — and the stock has spent the period covering most of that distance, leaving the current price in the upper quarter of its own one-year band rather than at either extreme.

At a market capitalization near $7.0 billion, the stock trades at about 39 times trailing earnings and roughly 26 times forward estimates, with a price-to-book ratio of about 4.6. The gap between those two earnings multiples reflects expectations of higher profits ahead. Profitability is thin in absolute terms — a net margin near 4% — which is characteristic of contract manufacturing, where scale rather than pricing power carries earnings; revenue growth of about 28% is what the market is pairing with that margin. A beta of 0.89 means the shares have historically moved slightly less than the broader market.

Recent headlines are notably light on company-specific developments. Much of the flow is industry research on end markets Plexus participates in — telecom electronic manufacturing services and medical device contract manufacturing — rather than news about the company itself. What is company-specific is largely procedural: scheduled appearances at the Raymond James and Stifel investor conferences and the release of a fiscal 2023 sustainability report. One headline referencing "Plex" concerns connected-TV apps and is unrelated to the company. For a reader, that means the current news record offers little fresh company-level detail, and the sector items describe the environment Plexus operates in rather than its own results.